Femme et Homme
- | Pays :
- United States
- Belgium
- France
- Les 2 autres...
- | Organes : -
- | Spécialités : -
Extrait
The current study is to evaluate: Overall response rate for the combination of trastuzumab and SU011248 in metastatic or locally recurrent breast cancer; evaluate safety and tolerability of the combination; measure duration of tumor control and survival; assess patient reported outcomes; assess PK in combination with trastuzumab and compare efficacy and safety.
Critère d'inclusion
- Breast Neoplasms